Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 3133-3142

  Gorman, Jacob V ^a   Starbeck Miller, Gabriel ^a   Pham, Nhat Long L ^a   Traver, Geri L ^a   Rothman, Paul B ^a   Harty, John T ^a   Colgan, John D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; GAMMA INTERFERON; MEMBRANE PROTEIN; PROTEIN BCL XL; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL TRANSFER; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; HOST-PATHOGEN INTERACTIONS; INTERFERON-GAMMA; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, VIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897534046     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302290     Document Type: Article

References (68)

1. Chen, L., and D. B. Flies. 2013. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13: 227-242.
2. Kane, L. P. 2010. T cell Ig and mucin domain proteins and immunity. J. Immunol. 184: 2743-2749.
3. Freeman, G. J., J. M. Casasnovas, D. T. Umetsu, and R. H. DeKruyff. 2010. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol. Rev. 235: 172-189.
4. Zhu, C., A. C. Anderson, and V. K. Kuchroo. 2011. TIM-3 and its regulatory role in immune responses. Curr. Top. Microbiol. Immunol. 350: 1-15.
5. Miyanishi, M., K. Tada, M. Koike, Y. Uchiyama, T. Kitamura, and S. Nagata. 2007. Identification of Tim4 as a phosphatidylserine receptor. Nature 450: 435-439.
6. Kobayashi, N., P. Karisola, V. Peña-Cruz, D. M. Dorfman, M. Jinushi, S. E. Umetsu, M. J. Butte, H. Nagumo, I. Chernova, B. Zhu, et al. 2007. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-940.
7. Nakayama, M., H. Akiba, K. Takeda, Y. Kojima, M. Hashiguchi, M. Azuma, H. Yagita, and K. Okumura. 2009. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113: 3821-3830.
8. DeKruyff, R. H., X. Bu, A. Ballesteros, C. Santiago, Y. L. Chim, H. H. Lee, P. Karisola, M. Pichavant, G. G. Kaplan, D. T. Umetsu, et al. 2010. T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J. Immunol. 184: 1918-1930.
9. de Souza, A. J., T. B. Oriss, K. J. O'malley, A. Ray, and L. P. Kane. 2005. T cell Ig and mucin 1 (TIM-1) is expressed on in vivo-activated T cells and provides a costimulatory signal for T cell activation. Proc. Natl. Acad. Sci. USA 102: 17113-17118.
10. de Souza, A. J., J. S. Oak, R. Jordanhazy, R. H. DeKruyff, D. A. Fruman, and L. P. Kane. 2008. T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase. J. Immunol. 180: 6518-6526.
11. van de Weyer, P. S., M. Muehlfeit, C. Klose, J. V. Bonventre, G. Walz, and E. W. Kuehn. 2006. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem. Biophys. Res. Commun. 351: 571-576.
12. Lee, J., E. W. Su, C. Zhu, S. Hainline, J. Phuah, J. A. Moroco, T. E. Smithgall, V. K. Kuchroo, and L. P. Kane. 2011. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol. Cell. Biol. 31: 3963-3974.
13. Curtiss, M. L., B. S. Hostager, E. Stepniak, M. Singh, N. Manhica, J. Knisz, G. Traver, P. D. Rennert, J. D. Colgan, and P. B. Rothman. 2011. Fyn binds to and phosphorylates T cell immunoglobulin and mucin domain-1 (Tim-1). Mol. Immunol. 48: 1424-1431.
14. Umetsu, S. E., W. L. Lee, J. J. McIntire, L. Downey, B. Sanjanwala, O. Akbari, G. J. Berry, H. Nagumo, G. J. Freeman, D. T. Umetsu, and R. H. DeKruyff. 2005. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat. Immunol. 6: 447-454.
15. Anderson, A. C., D. E. Anderson, L. Bregoli, W. D. Hastings, N. Kassam, C. Lei, R. Chandwaskar, J. Karman, E. W. Su, M. Hirashima, et al. 2007. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143.
16. Mariat, C., N. Degauque, S. Balasubramanian, J. Kenny, R. H. DeKruyff, D. T. Umetsu, V. Kuchroo, X. X. Zheng, and T. B. Strom. 2009. Tim-1 signaling substitutes for conventional signal 1 and requires costimulation to induce T cell proliferation. J. Immunol. 182: 1379-1385.
17. Kim, H. S., H. S. Kim, C. W. Lee, and D. H. Chung. 2010. T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J. Immunol. 184: 4095-4106.
18. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, et al. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541.
19. Sánchez-Fueyo, A., J. Tian, D. Picarella, C. Domenig, X. X. Zheng, C. A. Sabatos, N. Manlongat, O. Bender, T. Kamradt, V. K. Kuchroo, et al. 2003. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4: 1093-1101.
20. Ju, Y., N. Hou, J. Meng, X. Wang, X. Zhang, D. Zhao, Y. Liu, F. Zhu, L. Zhang, W. Sun, et al. 2010. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 52: 322-329.
21. Gleason, M. K., T. R. Lenvik, V. McCullar, M. Felices, M. S. O'Brien, S. A. Cooley, M. R. Verneris, F. Cichocki, C. J. Holman, A. Panoskaltsis-Mortari, et al. 2012. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 119: 3064-3072.
22. Ndhlovu, L. C., S. Lopez-Vergès, J. D. Barbour, R. B. Jones, A. R. Jha, B. R. Long, E. C. Schoeffler, T. Fujita, D. F. Nixon, and L. L. Lanier. 2012. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 119: 3734-3743.
23. Sehrawat, S., P. B. Reddy, N. Rajasagi, A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2010. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 6: e1000882.
24. Nagahara, K., T. Arikawa, S. Oomizu, K. Kontani, A. Nobumoto, H. Tateno, K. Watanabe, T. Niki, S. Katoh, M. Miyake, et al. 2008. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J. Immunol. 181: 7660-7669.
25. Nakae, S., M. Iikura, H. Suto, H. Akiba, D. T. Umetsu, R. H. Dekruyff, H. Saito, and S. J. Galli. 2007. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110: 2565-2568.
26. Zhao, J., Z. Lei, Y. Liu, B. Li, L. Zhang, H. Fang, C. Song, X. Wang, G. M. Zhang, Z. H. Feng, and B. Huang. 2009. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J. Immunol. 182: 6618-6624.
27. Chiba, S., M. Baghdadi, H. Akiba, H. Yoshiyama, I. Kinoshita, H. Dosaka-Akita, Y. Fujioka, Y. Ohba, J. V. Gorman, J. D. Colgan, et al. 2012. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat. Immunol. 13: 832-842.
28. Frisancho-Kiss, S., S. E. Davis, J. F. Nyland, J. A. Frisancho, D. Cihakova, M. A. Barrett, N. R. Rose, and D. Fairweather. 2007. Cutting edge: crossregulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J. Immunol. 178: 6710-6714.
29. Yang, X., X. Jiang, G. Chen, Y. Xiao, S. Geng, C. Kang, T. Zhou, Y. Li, X. Guo, H. Xiao, et al. 2013. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J. Immunol. 190: 2068-2079.
30. Zhang, Y., C. J. Ma, J. M. Wang, X. J. Ji, X. Y. Wu, Z. S. Jia, J. P. Moorman, and Z. Q. Yao. 2011. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection. PLoS ONE 6: e19664.
31. Tang, Z. H., S. Liang, J. Potter, X. Jiang, H. Q. Mao, and Z. Li. 2013. Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. J. Immunol. 190: 1788-1796.
32. Sehrawat, S., A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2009. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182: 3191-3201.
33. Sabatos, C. A., S. Chakravarti, E. Cha, A. Schubart, A. Sánchez-Fueyo, X. X. Zheng, A. J. Coyle, T. B. Strom, G. J. Freeman, and V. K. Kuchroo. 2003. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4: 1102-1110.
34. Lee, S. Y., and J. M. Goverman. 2013. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells. J. Immunol. 190: 4991-4999.
35. Zhu, C., A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, and V. K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6: 1245-1252.
36. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
37. Abdelbary, N. H., H. M. Abdullah, T. Matsuzaki, D. Hayashi, Y. Tanaka, H. Takashima, S. Izumo, and R. Kubota. 2011. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection. J. Infect. Dis. 203: 948-959.
38. Jin, H. T., A. C. Anderson, W. G. Tan, E. E. West, S. J. Ha, K. Araki, G. J. Freeman, V. K. Kuchroo, and R. Ahmed. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107: 14733-14738.
39. Sakuishi, K., L. Apetoh, J. M. Sullivan, B. R. Blazar, V. K. Kuchroo, and A. C. Anderson. 2010. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207: 2187-2194.
40. Golden-Mason, L., B. E. Palmer, N. Kassam, L. Townshend-Bulson, S. Livingston, B. J. McMahon, N. Castelblanco, V. Kuchroo, D. R. Gretch, and H. R. Rosen. 2009. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4 + and CD8+ T cells. J. Virol. 83: 9122-9130.
41. Kassu, A., R. A. Marcus, M. B. D'Souza, E. A. Kelly-McKnight, L. Golden- Mason, R. Akkina, A. P. Fontenot, C. C. Wilson, and B. E. Palmer. 2010. Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection. J. Immunol. 185: 3007-3018.
42. Moorman, J. P., J. M. Wang, Y. Zhang, X. J. Ji, C. J. Ma, X. Y. Wu, Z. S. Jia, K. S. Wang, and Z. Q. Yao. 2012. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J. Immunol. 189: 755-766.
43. Nebbia, G., D. Peppa, A. Schurich, P. Khanna, H. D. Singh, Y. Cheng, W. Rosenberg, G. Dusheiko, R. Gilson, J. ChinAleong, et al. 2012. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE 7: e47648.
44. Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12: 492-499.
45. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
46. Pope, C., S. K. Kim, A. Marzo, D. Masopust, K. Williams, J. Jiang, H. Shen, and L. Lefrançois. 2001. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J. Immunol. 166: 3402-3409.
47. Haring, J. S., V. P. Badovinac, M. R. Olson, S. M. Varga, and J. T. Harty. 2005. In vivo generation of pathogen-specific Th1 cells in the absence of the IFNgamma receptor. J. Immunol. 175: 3117-3122.
48. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
49. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191: 335-346.
50. Rai, D., N. L. Pham, J. T. Harty, and V. P. Badovinac. 2009. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J. Immunol. 183: 7672-7681.
51. Joshi, N. S., W. Cui, A. Chandele, H. K. Lee, D. R. Urso, J. Hagman, L. Gapin, and S. M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
52. Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640.
53. Obar, J. J., E. R. Jellison, B. S. Sheridan, D. A. Blair, Q. M. Pham, J. M. Zickovich, and L. Lefrançois. 2011. Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation. J. Immunol. 187: 4967-4978.
54. Sharma, S., A. Sundararajan, A. Suryawanshi, N. Kumar, T. Veiga-Parga, V. K. Kuchroo, P. G. Thomas, M. Y. Sangster, and B. T. Rouse. 2011. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc. Natl. Acad. Sci. USA 108: 19001-19006.
55. Takamura, S., S. Tsuji-Kawahara, H. Yagita, H. Akiba, M. Sakamoto, T. Chikaishi, M. Kato, and M. Miyazawa. 2010. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors. J. Immunol. 184: 4696-4707.
56. Reddy, P. B., S. Sehrawat, A. Suryawanshi, N. K. Rajasagi, S. Mulik, M. Hirashima, and B. T. Rouse. 2011. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J. Immunol. 187: 5745-5755.
57. Qiu, Y., J. Chen, H. Liao, Y. Zhang, H. Wang, S. Li, Y. Luo, D. Fang, G. Li, B. Zhou, et al. 2012. Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti- TB effector functions. PLoS Pathog. 8: e1002984.
58. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
59. Jayaraman, P., I. Sada-Ovalle, S. Beladi, A. C. Anderson, V. Dardalhon, C. Hotta, V. K. Kuchroo, and S. M. Behar. 2010. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J. Exp. Med. 207: 2343-2354.
60. Wilker, P. R., J. R. Sedy, V. Grigura, T. L. Murphy, and K. M. Murphy. 2007. Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family. Int. Immunol. 19: 763-773.
61. Cao, E., X. Zang, U. A. Ramagopal, A. Mukhopadhaya, A. Fedorov, E. Fedorov, W. D. Zencheck, J. W. Lary, J. L. Cole, H. Deng, et al. 2007. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligandbinding surface. Immunity 26: 311-321.
62. McMahan, R. H., L. Golden-Mason, M. I. Nishimura, B. J. McMahon, M. Kemper, T. M. Allen, D. R. Gretch, and H. R. Rosen. 2010. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 120: 4546-4557.
63. Wang, X., Z. Cao, J. Jiang, Y. Li, M. Dong, M. Ostrowski, and X. Cheng. 2011. Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis. J. Infect. 62: 292-300.
64. Wu, W., Y. Shi, S. Li, Y. Zhang, Y. Liu, Y. Wu, and Z. Chen. 2012. Blockade of Tim-3 signaling restores the virus-specific CD8+ T-cell response in patients with chronic hepatitis B. Eur. J. Immunol. 42: 1180-1191.
65. Ju, Y., N. Hou, X. N. Zhang, D. Zhao, Y. Liu, J. J. Wang, F. Luan, W. Shi, F. L. Zhu, W. S. Sun, et al. 2009. Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection. Cell. Mol. Immunol. 6: 35-43.
66. Ngiow, S. F., B. von Scheidt, H. Akiba, H. Yagita, M. W. Teng, and M. J. Smyth. 2011. Anti-TIM3 antibody promotes T cell IFN-g-mediated antitumor immunity and suppresses established tumors. Cancer Res. 71: 3540-3551.
67. Wherry, E. J., S. J. Ha, S. M. Kaech, W. N. Haining, S. Sarkar, V. Kalia, S. Subramaniam, J. N. Blattman, D. L. Barber, and R. Ahmed. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
68. Doering, T. A., A. Crawford, J. M. Angelosanto, M. A. Paley, C. G. Ziegler, and E. J. Wherry. 2012. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 37: 1130-1144.